{"title":"Racial inequities in opioid use disorder management: can the anesthesiologist improve outcomes?","authors":"Emmanuel Alalade, Brittany L Willer","doi":"10.1097/AIA.0000000000000383","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000383","url":null,"abstract":"","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"61 1","pages":"16-20"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10077386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katie J O'Conor, Lisa Young, Oluwakemi Tomobi, Sherita Hill Golden, Christelle D K Samen, Michael C Banks
{"title":"Implementing pathways to anesthesiology: Promoting diversity, equity, inclusion, and success.","authors":"Katie J O'Conor, Lisa Young, Oluwakemi Tomobi, Sherita Hill Golden, Christelle D K Samen, Michael C Banks","doi":"10.1097/AIA.0000000000000386","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000386","url":null,"abstract":",","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"61 1","pages":"34-41"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10077388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yelena Spitzer, Annery G Garcia-Marcinkiewicz, Elizabeth B Malinzak
{"title":"Programmatic approaches to achieving equity for women in anesthesiology.","authors":"Yelena Spitzer, Annery G Garcia-Marcinkiewicz, Elizabeth B Malinzak","doi":"10.1097/AIA.0000000000000388","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000388","url":null,"abstract":"• Women anesthesiologists can experience barriers and bias in the workplace, which varies in nature across their career and can negatively hinder professional development. • Mitigation of these barriers and discrimination can be achieved through: (1) addressing individual bias, (2) closing the knowledge gap on the scope of bias, (3) deliberate representation, (4) strengthening professional networks, and (5) organized efforts to create policies that address gender inequity in the workplace. • Women in anesthesiology is one example of several organized initiatives and programs that promote gender equity for women anesthesiologists of all identities.","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"61 1","pages":"42-48"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10129474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Travis L Reece-Nguyen, Luis Tollinche, Christian Van Rooyen, Remigio A Roque
{"title":"Current challenges faced by transgender and gender-diverse patients and providers in anesthesiology.","authors":"Travis L Reece-Nguyen, Luis Tollinche, Christian Van Rooyen, Remigio A Roque","doi":"10.1097/AIA.0000000000000384","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000384","url":null,"abstract":"The transgender and gender-diverse (TGD) population of the United States is estimated to be approximately 0.5% of the adult population or about 1.3 million adults. 1 Of those adults, 38.5% are transgender women, 35.9% are transgender men, and 25.6% are gender-diverse. 1 Mirroring the overall increase in the lesbian, gay, bisexual, transgender","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"61 1","pages":"26-33"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10077387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Left ventricular assist devices: review of historical context, clinical indications, and device-related adverse events.","authors":"Richa Dhawan","doi":"10.1097/AIA.0000000000000375","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000375","url":null,"abstract":"Left ventricular assist devices (LVADs) have revolutionized medical treatment for patients with end-stage heart failure (HF), a major contributor of morbidity and mortality in the United States and worldwide, with > 30 million people affected. Despite advances in pharmacological therapy, many people with HF have progressive disease necessitating escalation of medical and surgical care. Orthotopic heart transplantation is the gold standard and provides de fi nitive treatment for end-stage HF; however, short supply of donor hearts limits this option in many patients. LVADs have emerged as an alternative option, with escalation in usage in the last 2 decades. Widespread use of LVADs has decreased mortality and improved quality of life for patients with end-stage HF. Since their advent in the 1960s, LVAD use has evolved from bridge-to-transplant into destination therapy. 1 This study discusses the emergence of LVADs, current indications for use, types of devices, hemodynamic management, and limitations associated with their use. the 2-year follow-up long-term outcome assessed the and ef fi cacy of a for of HVAD","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"60 4","pages":"24-30"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10470410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mechanical circulatory support in the intensive care unit.","authors":"Philip Sommer, Mark Nunnally","doi":"10.1097/AIA.0000000000000381","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000381","url":null,"abstract":"Goals for mechanical circulatory support (MCS) have grown from facilitating surgical procedures 1 and supporting respiratory dysfunction 2,3 to minimizing iatrogenic harm, facilitating reha-bilitation, and sustaining patients in cardiogenic shock. MCS in the intensive care unit (ICU) should be thought of as a complete clinical service more than a technology because of the numerous clinical care issues that need to be assessed/addressed. intra-aortic balloon counterpulsation in the ICU setting, mainly on use of extracorporeal membrane oxygenation (ECMO) in the ICU.","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"60 4","pages":"46-54"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10470411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Total artificial heart system.","authors":"Michael Essandoh, Nicolas Kumar","doi":"10.1097/AIA.0000000000000377","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000377","url":null,"abstract":"Heart failure is a ubiquitous condition affecting over 60 million people globally and causes substantial morbidity and mortality. Conventionally, terminal heart failure is treated with guidelinedirected medical therapy and cardiac resynchronization therapy, which unfortunately becomes refractory over time, and necessitates escalation to advanced therapies or heart transplantation. Heart transplantation is the ultimate therapy for medically refractory advanced heart failure. Still, the limited supply of donor hearts (~4000 yearly) has spurred the development of mechanical circulatory support (MCS) strategies for heart failure treatment as bridge-to-decision making, bridge-to-myocardial recovery, bridge-to-orthotopic heart transplantation (BTT), and destination therapy (DT).","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"60 4","pages":"39-45"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10096557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mechanical circulatory support devices in noncardiac surgery.","authors":"Kristin C Trela","doi":"10.1097/AIA.0000000000000374","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000374","url":null,"abstract":"Mechanical circulatory support (MCS) devices are percutaneously or surgically implantable devices that support either the circulatory system, the pulmonary system, or both. Device tech-nology has improved over time, resulting in more patients using MCS, particularly left ventricular assist devices (LVAD). 1 In addition, the COVID-19 pandemic has brought MCS to the forefront due to the utilization of extracorporeal membrane oxygenation (ECMO) to support patients in profound respiratory failure. 2 The increase in MCS patients has led to more patients requiring anesthesia for noncardiac surgery (NCS), which can be secondary to the pathology that required MCS in the fi rst place, a complication of MCS, or an entirely separate pathology. 3 Thus, it is prudent for anesthesiologists to under-stand the basic principles of how these devices work to provide safe anesthetics. This article focuses on the general principles surrounding the preoperative evaluation of the MCS patient presenting for NCS, focusing on the most likely encountered devices in this scenario: the intra-aortic balloon pump (IABP), ECMO, and the LVAD.","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"60 4","pages":"55-63"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10094178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mechanical circulatory support devices: historical overview and modern approach.","authors":"Danisa K Daubenspeck","doi":"10.1097/AIA.0000000000000376","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000376","url":null,"abstract":"Heart failure (HF) continues to be a pervasive problem both nationally and globally, and with an aging population its prevalence is only increasing. It is estimated that ~6 million Americans over 20 years old were diagnosed with HF between 2015 and 2018, and projections estimate that the number will be > 8 million by 2030. There have been multiple classification systems developed to help risk stratify, prognosticate, and determine treatment forHF patients. These include theNewYork Heart Association (NYHA) functional classification, the American College of Cardiology (ACC) and American Heart Association (AHA) stages, and The Interagency Registry for Mechanically Assisted Circulation (INTERMACS) profiles. The ultimate goal of these systems is to provide early identification and create a pathway for intervention whether in the form of medical therapy, mechanical circulatory support (MCS), or a combination of both. The termMCS encompasses a wide variety of options ranging from percutaneous temporary devices used as a bridge-to-transplantation (BTT) or myocardial recovery to permanent implantable devices meant as destination therapy (DT). The MCS devices commonly used today include the intraaortic balloon pump (IABP), Impella (Abiomed, Danvers, MA), TandemHeart (LivaNova, London, UK), total artificial heart (TAH), venoarterial and veno-venous extracorporeal membrane oxygenation (VA-ECMO and VV-ECMO), durable left ventricular assist devices (LVAD), and percutaneous right ventricular assist devices (RVAD). Various models and configurations of these listed devices can be used to support the left or right ventricle individually (LV, RV), and some can be used to provide biventricular support. The who, what, andwhen ofMCS requires a multidisciplinary team approach, considering numerous variables in order to provide the optimal therapy for each individual patient. This article presents an overview of the history and indications for MCS, as well as how to select patients for MCS and a brief explanation of available devices.","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"60 4","pages":"1-7"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10094181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pulsatile versus nonpulsatile blood flow during cardiopulmonary bypass.","authors":"Mark A Chaney","doi":"10.1097/AIA.0000000000000378","DOIUrl":"https://doi.org/10.1097/AIA.0000000000000378","url":null,"abstract":"Evolution chose pulsatile blood fl ow; man developed pulseless perfusion. ” 1 Controversy surrounding the importance of pulsatile fl ow (PF) dates back to Hippocrates and Aristotle. 2 Development of cardiopulmonary bypass (CPB) in the 1950s accelerated the PF versus nonpulsatile fl ow (NPF) debate, which remains ongoing to this day. 3,4 Numerous animal studies reveal substantial potential bene fi ts of PF when compared with NPF in the acute setting of CPB (hours), but similar such comparisons in humans are not convincing. Increased use of continuous- fl ow left ventricular assist devices (CF-LVAD) has opened the door for quite unique pathophysiological manifestations of chronic NPF (months/ years).","PeriodicalId":46852,"journal":{"name":"INTERNATIONAL ANESTHESIOLOGY CLINICS","volume":"60 4","pages":"8-15"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10087419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}